Kathy Turner V - 14 Feb 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Reporting relationship: Senior Vice President
Issuer ticker: IDXX
Reported as of: 14 Feb 2023
Net transaction value: -$997,678
SEC form: 4
Accepted by SEC: 16 Feb 2023, 17:56:07 UTC
Prior SEC filing: 13 Feb 2023
Next SEC filing: 17 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Lily J. Lu, Attorney-in-Fact for Kathy V. Turner

Key filing fact

Kathy Turner V filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 16 Feb 2023.

Key facts

This page summarizes Kathy Turner V's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
17 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 16 Feb 2023, 17:56.

Change

Previous filing in this sequence was filed on 13 Feb 2023.
Current net transaction value: -$997,678.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDXX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +210
Change %: +3%
Price: $0.000000
Shares after: 7,151
Date: 14 Feb 2023
Ownership: Direct

IDXX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +181
Change %: +2.5%
Price: $0.000000
Shares after: 7,332
Date: 14 Feb 2023
Ownership: Direct

IDXX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +162
Change %: +2.2%
Price: $0.000000
Shares after: 7,440
Date: 14 Feb 2023
Ownership: Direct

IDXX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +86
Change %: +1.1%
Price: $0.000000
Shares after: 7,580
Date: 14 Feb 2023
Ownership: Direct

IDXX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +93
Change %: +1.2%
Price: $0.000000
Shares after: 7,673
Date: 14 Feb 2023
Ownership: Direct

IDXX transaction

Common Stock

Tax liability

Transaction value: $147,569
Shares: -293
Change %: -3.8%
Price: $503.65
Shares after: 7,380
Date: 14 Feb 2023
Ownership: Direct

IDXX transaction

Common Stock

Options Exercise

Transaction value: $159,080
Shares: +2,000
Change %: +27%
Price: $79.54^*
Shares after: 9,380
Date: 14 Feb 2023
Ownership: Direct

IDXX transaction

Common Stock

Sale

Transaction value: $505,059
Shares: -1,000
Change %: -11%
Price: $505.06
Shares after: 8,380
Date: 14 Feb 2023
Ownership: Direct
Footnotes: F1

IDXX transaction

Common Stock

Sale

Transaction value: $157,959
Shares: -313
Change %: -3.7%
Price: $504.66
Shares after: 8,067
Date: 14 Feb 2023
Ownership: Direct
Footnotes: F2

IDXX transaction

Common Stock

Sale

Transaction value: $290,861
Shares: -577
Change %: -7.2%
Price: $504.09
Shares after: 7,490
Date: 14 Feb 2023
Ownership: Direct
Footnotes: F3

IDXX transaction

Common Stock

Sale

Transaction value: $55,310
Shares: -110
Change %: -1.5%
Price: $502.81
Shares after: 7,380
Date: 14 Feb 2023
Ownership: Direct
Footnotes: F4

IDXX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 100
Date: 14 Feb 2023
Ownership: by spouse
Footnotes: F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -210
Change %: -14%
Price
Shares after: 1,315
Date: 14 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 210
Exercise price
Footnotes: F6, F12

IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -181
Change %: -14%
Price
Shares after: 1,134
Date: 14 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 181
Exercise price
Footnotes: F7, F12

IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -162
Change %: -14%
Price
Shares after: 972
Date: 14 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 162
Exercise price
Footnotes: F8, F12

IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -86
Change %: -8.8%
Price
Shares after: 886
Date: 14 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 86
Exercise price
Footnotes: F9, F12

IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -93
Change %: -10%
Price
Shares after: 793
Date: 14 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 93
Exercise price
Footnotes: F10, F12

IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares: -2,000
Change %: -30%
Price
Shares after: 4,736
Date: 14 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000
Exercise price: $79.54
Footnotes: F11, F12

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Represents the weighted average price of the shares sold ranging from a low of $505.00 to a high of $505.225 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F2

Represents the weighted average price of the shares sold ranging from a low of $504.49 to a high of $504.75 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F3

Represents the weighted average price of the shares sold ranging from a low of $503.43 to a high of $504.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F4

Represents the weighted average price of the shares sold ranging from a low of $502.42 to a high of $503.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F5

The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.

Footnote F6

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.

Footnote F7

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

Footnote F8

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

Footnote F9

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

Footnote F10

Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

Footnote F11

Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

Footnote F12

Not applicable.